GGI
GILD icon

Godsey & Gibb Inc’s Gilead Sciences GILD Stock Holding History

Godsey & Gibb Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-600
Closed -$48.6K – 397
2023
Q4 		$48.6K Buy
+600
New +$46.7K 0.01% 164
2023
Q1 		– Sell
-20
Closed -$1.72K – 361
2022
Q4 		$1.72K Buy
+20
New +$1.58K ﹤0.01% 269

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Godsey & Gibb Inc's GILD Position: Q1 2024 in Review

Godsey & Gibb Inc sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 600 shares — an estimated $48.6K sold.

Godsey & Gibb Inc first reported a position in GILD in Q4 2022 and held it in 2 quarters. The position peaked at $48.6K in Q4 2023. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Godsey & Gibb Inc reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Godsey & Gibb Inc sold 600 Gilead Sciences shares in Q1 2024, an estimated $48.6K.
  • Godsey & Gibb Inc first reported a position in Gilead Sciences in Q4 2022 and held it in 2 quarters.
  • Godsey & Gibb Inc's Gilead Sciences position peaked at $48.6K in Q4 2023.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Godsey & Gibb Inc's 13F filing for Q1 2024, filed 23 Apr 2024.